• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过神经激肽受体激活介导的大鼠胃肠运动反应。

Rat gastrointestinal motor responses mediated via activation of neurokinin receptors.

作者信息

Chang F Y, Lee S D, Yeh G H, Wang P S

机构信息

Division of Gastroenterology, Veterans General Hospital-Taipei, Taiwan, Republic of China.

出版信息

J Gastroenterol Hepatol. 1999 Jan;14(1):39-45. doi: 10.1046/j.1440-1746.1999.01808.x.

DOI:10.1046/j.1440-1746.1999.01808.x
PMID:10029276
Abstract

Natural neurokinins (NK) and their specific receptor agonists, including substance P (SP), neurokinin A (NKA), neurokinin B (NKB), septide, [NIe10]-NKA4-10 and senktide, were used to assess whether they could activate established NK receptors in rat gastrointestinal tract and central nervous system to alter gastric emptying or intestinal transit. Fasting rats were intubated with an orogastric catheter to feed them liquid radiochromium. Neurokinins and analogues (at 10(-10), 10(-9), 10(-8) and 10(-7) mol/kg) and vehicle (saline + 0.1% bovine serum albumin) were injected via an intraperitoneal route. Rats were killed 15 min later and the whole gut was removed. The radioactivity of the stomach and 10 equally divided small intestinal segments was counted to determine gastric emptying and the geometric centre of intestinal transit. Septide treatment at 10(-8) and 10(-7) mol/kg markedly delayed gastric emptying. All doses of NKA inhibited gastric emptying. However, other peptides did not influence gastric emptying. Both septide and NKB treatment at 10(-8) and 10(-7) mol/kg enhanced intestinal transit. Substance P or senktide treatment (10-(-7) mol/kg) also enhanced intestinal transit. Stasis of remaining radioactivity in the proximal intestine was found following SP, septide, NKA and NKB treatment, whereas accelerated transit in the distal intestine was induced following NKA, NKB and senktide treatment. In conclusion, the in vivo study of NK and their specific agonists manifests a selective influence of these compounds on rat gastrointestinal tract. This selective activation of stomach NK1 and NK2 receptors delays gastric emptying, whereas activation of intestinal NK1 and NK3 receptors enhances intestinal transit.

摘要

天然神经激肽(NK)及其特异性受体激动剂,包括P物质(SP)、神经激肽A(NKA)、神经激肽B(NKB)、七肽、[Nle10]-NKA4-10和速激肽,用于评估它们是否能激活大鼠胃肠道和中枢神经系统中已确立的NK受体,从而改变胃排空或肠道转运。禁食大鼠经口胃导管插管,给它们喂食液体放射性铬。神经激肽及其类似物(浓度为10^(-10)、10^(-9)、10^(-8)和10^(-7) mol/kg)以及赋形剂(生理盐水+0.1%牛血清白蛋白)通过腹腔内途径注射。15分钟后处死大鼠,取出整个肠道。对胃和10个等长的小肠段进行放射性计数,以确定胃排空和肠道转运的几何中心。10^(-8)和10^(-7) mol/kg剂量的七肽处理显著延迟胃排空。所有剂量的NKA均抑制胃排空。然而,其他肽对胃排空没有影响。10^(-8)和10^(-7) mol/kg剂量的七肽和NKB处理均增强肠道转运。P物质或速激肽处理(10^(-7) mol/kg)也增强肠道转运。SP、七肽、NKA和NKB处理后,近端肠道中剩余放射性物质出现停滞,而NKA、NKB和速激肽处理后,远端肠道出现转运加速。总之,对NK及其特异性激动剂的体内研究表明,这些化合物对大鼠胃肠道有选择性影响。胃NK1和NK2受体的这种选择性激活会延迟胃排空,而肠道NK1和NK3受体的激活则会增强肠道转运。

相似文献

1
Rat gastrointestinal motor responses mediated via activation of neurokinin receptors.通过神经激肽受体激活介导的大鼠胃肠运动反应。
J Gastroenterol Hepatol. 1999 Jan;14(1):39-45. doi: 10.1046/j.1440-1746.1999.01808.x.
2
The motor actions of natural neurokinins and their specific agonists on the gastrointestinal tract of the rat.天然神经激肽及其特异性激动剂对大鼠胃肠道的运动作用。
Chin J Physiol. 1992;35(4):337-48.
3
Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.介导新生大鼠脊髓中速激肽诱发神经元去极化的受体。
Acta Biol Hung. 1996;47(1-4):129-44.
4
Demonstration of a 'septide-sensitive' inflammatory response in rat skin.大鼠皮肤中“septide敏感”炎症反应的证明。
Br J Pharmacol. 1995 Oct;116(4):2170-4. doi: 10.1111/j.1476-5381.1995.tb15050.x.
5
Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.小鼠中的神经激肽受体(NK1、NK2):一项药理学研究。
Can J Physiol Pharmacol. 1997 Jun;75(6):552-7.
6
Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.中枢给予速激肽对大鼠心血管及行为的影响:用选择性拮抗剂对受体进行特性描述
Br J Pharmacol. 1994 May;112(1):240-9. doi: 10.1111/j.1476-5381.1994.tb13058.x.
7
Multiple types of tachykinin receptor mediate a slow excitation of rat spinal motoneurones in vitro.多种速激肽受体在体外介导大鼠脊髓运动神经元的缓慢兴奋。
Neurosci Lett. 1994 Jan 3;165(1-2):84-8. doi: 10.1016/0304-3940(94)90715-3.
8
Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.大鼠小肠中多种神经激肽受体对不规则峰电位活动的介导作用。
Br J Pharmacol. 1998 Jan;123(1):63-70. doi: 10.1038/sj.bjp.0701585.
9
Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.速激肽在孤束核中的呼吸作用:使用选择性激动剂和拮抗剂对受体进行表征
Br J Pharmacol. 2000 Mar;129(6):1121-31. doi: 10.1038/sj.bjp.0703172.
10
Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.中枢速激肽NK3受体在新型速激肽PG-KII对大鼠结肠推进作用中的抑制效应
Eur J Pharmacol. 1999 Jul 2;376(1-2):67-71. doi: 10.1016/s0014-2999(99)00354-4.

引用本文的文献

1
Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders.阿瑞匹坦对胃轻瘫及相关疾病患者的恶心有混合作用,并能减轻其他症状。
Gastroenterology. 2018 Jan;154(1):65-76.e11. doi: 10.1053/j.gastro.2017.08.033. Epub 2017 Oct 28.
2
The role of cholecystokinin 1 receptor in prolactin inhibited gastric emptying of male rat.胆囊收缩素 1 受体在催乳素抑制雄性大鼠胃排空中的作用。
J Neurogastroenterol Motil. 2012 Oct;18(4):385-90. doi: 10.5056/jnm.2012.18.4.385. Epub 2012 Oct 9.
3
Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.
大鼠结肠中神经激肽受体亚型对黏膜肌层和上皮功能贡献的区域差异。
Dig Dis Sci. 2006 Mar;51(3):506-16. doi: 10.1007/s10620-006-3163-6.
4
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.用于治疗肠易激综合征的速激肽NK2受体拮抗剂。
Br J Pharmacol. 2004 Apr;141(8):1249-63. doi: 10.1038/sj.bjp.0705751. Epub 2004 Mar 22.
5
Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.神经激肽NK1和NK3受体作为治疗胃肠动力障碍和疼痛药物的靶点。
Br J Pharmacol. 2004 Apr;141(8):1303-12. doi: 10.1038/sj.bjp.0705742. Epub 2004 Mar 15.